Men's immune response to brain protein may explain their higher rates of Parkinson's disease
Scientists at La Jolla Institute for Immunology (LJI) have found a potential new target for treating Parkinson's disease.
La Jolla News Nuggets: Home project appeal; restaurant site work; sinkhole repaired; more
“The lower the amount of an antibody you can deliver to someone, the easier it will be to manufacture a treatment, and the ...
New Ebola virus research boosts pandemic preparedness
New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb ...
News Medical on MSN21h
As dengue spreads, researchers discover a clue to fighting the virus
This research comes as dengue-carrying mosquitos expand their territory into new regions, including Southern California.
News Medical on MSN6d
Stopping asthma in its tracks
"If we can target these molecules in human patients, they might be able to develop long-lasting tolerance to allergens." ...
News Medical on MSN3d
New human antibody shows promise for Ebola virus treatment
New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus ...
technologynetworks5d
Developing Long-Lasting Relief for Asthma Patients
Two therapeutic "cocktails" could stop immune cells from overreacting to allergens, providing long-lasting asthma relief.
New asthma 'cocktail' could be game-changer for millions and reduce need for inhalers
A team of researchers have discovered a new 'cocktail' of drugs that could help those with asthma and other respiratory ...